» Articles » PMID: 34858513

Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study

Overview
Date 2021 Dec 3
PMID 34858513
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha ( (L.) Dunal), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress and improving memory. This double-blind, randomized, placebo-controlled clinical study evaluated the effect of Ashwagandha root extract sustained-release capsule 300 mg (Prolanza™; hereafter Ashwagandha SR) on cognitive functions, stress levels, sleep quality, overall well-being, and safety in stressed subjects.

Methods: Subjects (130 healthy cognitively sound adults [20-55 years, body mass index:18-29 kg/m]) having a Perceived Stress Scale (PSS) score of 14-24 were randomized to receive either Ashwagandha SR or placebo. Subjects took one capsule of Ashwagandha SR or placebo daily for 90 consecutive days. This study was registered on Clinical Trials Registry-India (CTRI) on 13/11/2019 [number: CTRI/2019/11/021990]. The primary endpoint was the change in cognitive function as measured by CANTAB from baseline to the end of the study period (90 ± 7 days). The secondary outcomes included the change in PSS-10 score, serum cortisol level (9-11 am), the OHQ score, the PSQI, and serum BDNF levels.

Results: Only 125 completed the study and were evaluated. The Cambridge Neuropsychological Test Automated Battery (CANTAB) reported significantly improved recall memory, and the total error rate in recalling patterns significantly decreased at visit 4 in the Ashwagandha SR group vs. the placebo group (first attempt memory score:12.9 ± 6.7 vs. 10.1 ± 6.3; total errors:17.5 ± 23.3 vs. 27.7 ± 23.6). At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6; < .0001), serum cortisol levels (=0.0443), and Pittsburgh Sleep Quality Index (PSQI) score ( < .0001) but higher Oxford Happiness Questionnaire (OHQ) scores ( < .0001) were seen in Ashwagandha SR vs. the placebo group, suggesting significantly lower stress levels and significantly better psychological well-being and sleep quality in the former. No adverse events were reported.

Conclusions: This is the first clinical study assessing Ashwagandha SR for its safety and efficacy. Treatment with one Ashwagandha SR capsule once daily for 90 days improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.

Citing Articles

Effects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes.

Coope O, Reales Salguero A, Spurr T, Paez Calvente A, Domenech Farre A, Jordan Fisas E Eur J Sport Sci. 2025; 25(3):e12265.

PMID: 39954269 PMC: 11829707. DOI: 10.1002/ejsc.12265.


Withania somnifera (Ashwagandha) supplementation: a review of its mechanisms, health benefits, and role in sports performance.

Sprengel M, Laskowski R, Jost Z Nutr Metab (Lond). 2025; 22(1):9.

PMID: 39910586 PMC: 11800443. DOI: 10.1186/s12986-025-00902-7.


Ashwagandha's Multifaceted Effects on Human Health: Impact on Vascular Endothelium, Inflammation, Lipid Metabolism, and Cardiovascular Outcomes-A Review.

Wicinski M, Fajkiel-Madajczyk A, Kurant Z, Liss S, Szyperski P, Szambelan M Nutrients. 2024; 16(15).

PMID: 39125360 PMC: 11314093. DOI: 10.3390/nu16152481.


Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.

Leonard M, Dickerson B, Estes L, Gonzalez D, Jenkins V, Johnson S Nutrients. 2024; 16(12).

PMID: 38931168 PMC: 11207027. DOI: 10.3390/nu16121813.


A standardized combination of and extracts enhances immune function in adults: a pilot randomized, double-blind, placebo-controlled clinical study.

Sadhupati D, Lakshmisudha R, Chakravarthy K, Naidana P Food Nutr Res. 2024; 68.

PMID: 38863743 PMC: 11165258. DOI: 10.29219/fnr.v68.10297.


References
1.
Harris P, Cooper K, Relton C, Thomas K . Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012; 66(10):924-39. DOI: 10.1111/j.1742-1241.2012.02945.x. View

2.
Notaras M, van den Buuse M . Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders. Mol Psychiatry. 2020; 25(10):2251-2274. DOI: 10.1038/s41380-019-0639-2. View

3.
Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M . Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020; 16(1):57. PMC: 7338126. DOI: 10.1186/s12992-020-00589-w. View

4.
Grover S, Sahoo S, Mehra A, Avasthi A, Tripathi A, Subramanyan A . Psychological impact of COVID-19 lockdown: An online survey from India. Indian J Psychiatry. 2020; 62(4):354-362. PMC: 7597717. DOI: 10.4103/psychiatry.IndianJPsychiatry_427_20. View

5.
Laufs U, Rettig-Ewen V, Bohm M . Strategies to improve drug adherence. Eur Heart J. 2010; 32(3):264-8. DOI: 10.1093/eurheartj/ehq297. View